News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

GE Recombinant Drugs & Threatening Reactions

GE Recombinant Drugs Result In Life Threatening Reactions
GE free NZ
Press Release

It is time that full stock is taken over the hazards and horrors that surround GE recombinant drugs that have genes from multiple animal species. (A recombinant product is created by sourcing DNA from two or more organisms, often from different animal or plant species (foreign genes) into a single recombinant molecule using bacterial or viral vectors).

The latest disaster of the recombinant cloned bio pharmaceutical human phase 1 clinical trial of TGN1412, has ended in a life threatening severe allergic (anaphylactic) reaction that many scientists have been warning about for years.

“The irresponsible panicked rush to put a GE drug on the market has caused many blunders and failures but none as big as this. The revolving door politics by big pharma-companies has allowed short cuts and safety parameters to be whittled down, ending up treating humans as guinea pigs”. said Claire Bleakley of GE Free (NZ) in food and environment.

“There is still little known about the mixing of genes across species barriers and the virulent immune system reactions that might occur”.

TGN1412 has been created by Te Genero and had reached the Phase 1 stage of human clinical trials after being given Orphan status the year before. The human recombinant pharmaceutical had shown that, in test tube experiments, the potential for the immune system to be fully stimulated by activating T lymphocytes, had therapeutic potential for a number of autoimmune/ inflammatory as well as cancer diseases.

However there have been deaths from GE trials going wrong over the years. Jesse Gelsinger died after severe immune reaction following gene therapy, three children developed mouse leukemia after the gene vector mutated. The failure of the PPL cystic fibrosis and the Multiple Sclerosis recombinant trials were due to severe immune reactions causing breathing and wheezing distress.

In 1989 a GE L-Tryptophan supplement, manufactured by Showa Denko in E-coli, caused Eosinophilia Myalgia Syndrome and ended in 100 deaths 1500 people to become permanently disabled.

This incident calls into doubt whether ERMA and AgResearch have taken into account the full risks associated with the creation of the GE human Lactoferrin Cows. ERMA approved the importing of embryos containing the Human lactoferrin for a supplement in neonates and immune compromised people.

As supplements do not have to be clinically trialed there is danger that we might have a similar devastating outcome of TGN1412 bio pharmaceutical sourced from a human/mouse clone.
We hope that ERMA considers these unforeseen, un- predictable and devastating outcome of meddling with nature and crossing all species barriers and moves demand that full clinical trials are conducted on the GE milk before the trials goes any further.

It is a sad outcome and our thoughts go out to the families whose loved ones are in intensive care”.

ENDS:


References:

Parexel International statement regarding Tegenero ag phase i trial at northwick park hospital, U.K.

Luhder.F, Huang.Y, Dennehy.K, Guntermann.C, Muller.I, Winkler.E, Kerkau.T, Ikemizu.S, Davis.S, Hanke.T, Hunig.T, (2003)Topological requirements and signaling properties of T cell-activating, Anti-CD28 Antibody superagonists. J.of Experimental Medicine, Vol: 197: 8, 955-966. http://www.abayfor.de/fv/forimmun/downloads/lhder_f_j_exp_med_2003.pdf


Tsokos M. and Paulsen E. Expression of pulmonary lactoferrin in sudden onset and
slow onset asthma with fatal outcome. Virchows Arch. 2002, 441, 494-99.

Terje Traavik, PhD +47 9581 7537, terjet@genok.org,
see also: Filipino farmers show GM pollen reaction, says scientist (Reuters)
http://www.cropchoice.com/leadstry.asp?RecID=2404
'First evidence' of GM health-risk (Farmers Weekly interactive - registration required)
http://www.fwi.co.uk/article.asp?con=13924&sec=18&hier=2

PPL Annual Report 2002.


© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Howard Davis Article: A Musical Axis - Brahms, Wagner, Sibelius

Brahms' warm and exquisitely subtle Symphony No. 3 in F major, Wagner's irrepressibly sentimental symphonic poem Siegfried Idyll, and Sibelius' chilling and immensely challenging Violin Concerto in D minor exemplify distinct stages of development in a tangled and convoluted series of skirmishes that came to define subsequent disputes about the nature of post-Romantic orchestral writing well into the following century. More>>

ALSO:

Scoop Review Of Books: A Pale Ghost Writer

Reviewed by Ruth Brassington, Richard Flanagan's new novel is about a novelist hastily ghost-writing the biography of a crook about to go to trial. The reader is kept on a cliff-edge, as the narrator tries to get blood out of his stone man. More>>

Negotiations Begin: Equal Conditions For Men & Women In Professional Football

The trade union representing New Zealand's professional footballers has initiated bargaining for an agreement securing equal terms and conditions for men and women. If negotiated, it will be the first agreement of its kind in the world. More>>

ALSO:


New Zealand Wars Commemoration: Witi Ihimaera's Sleeps Standing Moetū

The second of several articles to mark Rā Maumahara, remembering the New Zealand Land Wars. The first was a Q&A with Vincent O’Malley, author of The Great War for New Zealand: Waikato 1800–2000. More>>

ALSO:


Howard Davis Review: Conflict & Resistance - Ria Hall's Rules of Engagement

From the aftermath of war through colonisation to her own personal convictions, Hall's new CD addresses current issues and social problems on multiple levels, confirming her position as a polemical and preeminent voice on the indigenous NZ music scene. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland